Skip to main content
SpringerLink
Log in

Histoplasmosis in veterans administration hospitals in middle America

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

A series of clinical studies of histoplasmosis based on demonstrations of etiology led to descriptions of chronic pulmonary histoplasmosis, the principal type in adults, and amphotericin B as an effective therapy. A participant recreates the atmosphere of discovery during the contributions of a team comprising a mycologist, a surgeon and two physicians using cultures of exised lung and sputum to clearly identify cases of chronic pulmonary histoplasmosis. Subsequently cooperating physicians in several V.A. Hospitals carried out randomized studies of treatment, dosage, and side effects that established Amphotericin B as the sole curative therapy for chronic pulmonary histoplasmosis for 20 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baum, A. & Schwarz, J., 1962. Chronic Pulmonary Histoplasmosis. American Journal of Medicine 33: 873–879.

    Google Scholar 

  2. Conant, N. F., Smith, D. T., Baker, R. D., Martin, S. D. & Calloway, J. L., 1944. Manual of Clinical Mycology. 1st Ed., Philadelphia, PA. W. B. Saunders and Co.

    Google Scholar 

  3. Furcolow, M. L., 1950. Further Observation On Histoplasmosis. Mycology and Bacteriology. Public Health Reports 65: 965–994.

    Google Scholar 

  4. Furcolow, M. L. & Brasher, C. A., 1954. Chronic Progressive (Cavitary) Pulmonary Histoplasmosis As A Problem in Tuberculosis Sanitoriums. American Review of Tuberculosis 73: 609.

    Google Scholar 

  5. Furcolow, M. L., 1963. Comparison of Treated and Untreated Severe Histoplasmosis. A National Communicable Disease Cooperative Mycoses Study. Journal of the American Medical Association 183: 823–829.

    Google Scholar 

  6. Goodwin, R. A., Owens, F. T., Snell, J. T., Hubbard, W. W., Buchanan, R. D., Terry, R. J. & Des Pres, R. M., 1976. Chronic Pulmonary Histoplasmosis. Medicine 55: 413–452.

    Google Scholar 

  7. Goodwin, R. A., Owens, F. T., Snell, J. T., Hubbard, W. W., Buchanan, R. D., Terry, R. J. & Des Pres, R. M., 1976. Chronic Pulmonary Histoplasmosis. Medicine 55: 445–446.

    Google Scholar 

  8. Johnson, H. E. & Batson, R., 1948. Benign Pulmonary Histoplasmosis: A Case Report with Brief Review of Literature. Diseases of the Chest 14: 157.

    Google Scholar 

  9. Meleney, H. E., 1940. Histoplasmosis (Reticulo-Endothelio-Cytomycosis) A Review. American Journal of Tropical Medicine 20: 603–616.

    Google Scholar 

  10. Seabury, J. H. & Dascomb, H. E., 1958. Experience with Amphotericin B for the Treatment of Systemic Mycoses. Archives of Internal Medicine 102: 96–101.

    Google Scholar 

  11. Sutliff, W. D., 1961. Histoplasmosis Cooperative Study I. Frequency of Histoplasmosis Among Adult Hospitalized Males. VA-Armed Forces Cooperative Study on Histoplasmosis. American Review of Respiratory Disease 84:663–668.

    Google Scholar 

  12. Sutliff, W. D., Hughes, F. U. E. & Burkett, L. L., 1953. Active Chronic Pulmonary Histoplasmosis. American Medical Association Archives of Internal Medicine 92: 571–586.

    Google Scholar 

  13. Sutliff, W. D., 1964. Histoplasmosis Cooperative Study II. Chronic Pulmonary Histoplasmosis Treated with and without Amphotericin B. American Review of Respiratory Disease 89: 641–650.

    Google Scholar 

  14. Sutliff, W. D., 1971. Therapeutic Trials of Amphotericin B for the Treatment of Histoplasmosis. Histoplasmosis. Proceedings of the Second National Conference. Charles C. Thomas, Springfield, Ill.

    Google Scholar 

  15. Sutliff, W. D., 1972. Histoplasmosis Cooperative Study V. Amphotericin B Dosage for Chronic Pulmonary Histoplasmosis. American Review of Respiratory Disease 105: 60–67.

    Google Scholar 

  16. Utz, J. P., Louria, D. B., Feder, M., Emmons, C. W. & McCullough, N. B., 1958. A report of clinical studies in the use of Amphotericin B in patients with systemic fungal disease. Antibiotics Annual. 685–701.

  17. Utz, J. P., Tregor, A., McCullough, N. B. & Emmons, C. W., 1959. Amphotericin B: Intravenous use in patients with systemic fungal disease. Antibiotics Annual. 628–634.

Download references

Author information

Authors and Affiliations

  1. University of Tennessee Center for Health Sciences, Memphis, TN, USA

    Wheelan D. Sutliff

Authors
  1. Wheelan D. Sutliff
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dr. Sutliff died March 19, 1983

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sutliff, W.D. Histoplasmosis in veterans administration hospitals in middle America. Mycopathologia 83, 57–62 (1983). https://doi.org/10.1007/BF00437414

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00437414

Keywords

Search

Navigation